Phase 0/I/II Cancer Prevention Clinical Trials Program Clinical Trials

Title	Intervention	NCT ID	Sponsor	Status
Afimoxifene in Reducing the Risk of Breast Cancer in Women With Mammographically Dense Breast	Afimoxifene, Laboratory Biomarker Analysis, Placebo, Questionnaire Administration	NCT03063619	M.D. Anderson Cancer Center	Recruiting
Alternative Dosing of Exemestane Before Surgery in Treating Postmenopausal Patients With Stage 0-II...	Exemestane, Laboratory Biomarker Analysis, Pharmacological Study, Quality-of-Life Assessment, Questionnaire Administration, Therapeutic Conventional Surgery, Placebo Administration	NCT02598557	National Cancer Institute (NCI)	Active, not recruiting
Aspirin and Zileuton and Biomarker Expression in Nasal Tissue of Current Smokers	Aspirin, Laboratory Biomarker Analysis, Zileuton, Placebo Administration	NCT02348203	National Cancer Institute (NCI)	Active, not recruiting
Aspirin in Preventing Colorectal Cancer in Patients With Colorectal Adenoma	Aspirin, Laboratory Biomarker Analysis, Questionnaire Administration, Placebo Administration	NCT02965703	National Cancer Institute (NCI)	Recruiting
Aspirin in Preventing Disease Recurrence in Patients With Barrett Esophagus After Successful...	Aspirin, Laboratory Biomarker Analysis, Questionnaire Administration, Placebo Administration	NCT02521285	National Cancer Institute (NCI)	Active, not recruiting
Berberine Chloride in Preventing Colorectal Cancer in Patients With Ulcerative Colitis in Remission	Berberine Chloride, Laboratory Biomarker Analysis, Placebo Administration	NCT02365480	National Cancer Institute (NCI)	Active, not recruiting
Broccoli Sprout/Broccoli Seed Extract Supplement in Decreasing Toxicity in Heavy Smokers	Broccoli Sprout/Broccoli Seed Extract Supplement, Laboratory Biomarker Analysis, Questionnaire Administration	NCT03402230	National Cancer Institute (NCI)	Active, not recruiting
Curcumin in Preventing Gastric Cancer in Patients With Chronic Atrophic Gastritis or Gastric...	Curcumin, Laboratory Biomarker Analysis, Quality-of-Life Assessment, Placebo Administration	NCT02782949	National Cancer Institute (NCI)	Active, not recruiting
Defined Green Tea Catechin Extract in Preventing Liver Cancer in Patients With Cirrhosis	Defined Green Tea Catechin Extract, Laboratory Biomarker Analysis, Pharmacological Study, Questionnaire Administration	NCT03278925	National Cancer Institute (NCI)	Recruiting
DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus Infection	Electroporation-Mediated Plasmid DNA Vaccine Therapy, HCV DNA Vaccine INO-8000, Laboratory Biomarker Analysis, Quality-of-Life Assessment, Rocakinogene Sifuplasmid	NCT02772003	National Cancer Institute (NCI)	Active, not recruiting

Pages